Asahi Life Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$358K	Buy	1,083 +50	+5%	+$17K	0.23%	93
2025 Q4	$411K	Sell	1,033 -10	-1%	-$4.43K	0.23%	109
2025 Q3	$476K	Sell	1,043 -237	-19%	-$96.5K	0.26%	73
2025 Q2	$417K	Sell	1,280 -160	-11%	-$44.3K	0.24%	94
2025 Q1	$389K	Sell	1,440 -40	-3%	-$10.3K	0.25%	98
2024 Q4	$348K	Sell	1,480 -120	-8%	-$31.6K	0.21%	113
2024 Q3	$440K	Buy	+1,600	New	+$417K	0.27%	84
2024 Q2	–	Sell	-2,150	Closed	-$321K	–	151
2024 Q1	$321K	Buy	+2,150	New	+$359K	0.19%	139
2021 Q2	–	Sell	-2,610	Closed	-$369K	–	242
2021 Q1	$369K	Buy	+2,610	New	+$393K	0.05%	158
2020 Q3	–	Sell	-2,380	Closed	-$353K	–	235
2020 Q2	$353K	Sell	2,380 -1,720	-42%	-$232K	0.06%	110
2020 Q1	$446K	Buy	4,100 +920	+29%	+$106K	0.08%	93
2019 Q4	$366K	Buy	+3,180	New	+$317K	0.05%	158